CBGL (Cannabis Global) EBIT: $1.38 Mil (TTM As of May. 2022)


What is Cannabis Global EBIT?

Cannabis Global CBGL EBIT is $1.38 Mil as of May. 2022.

Cannabis Global's earnings before interest and taxes (EBIT) for the three months ended in May. 2022 was $-0.21 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in May. 2022 was $1.38 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Cannabis Global's annualized ROC % for the quarter that ended in May. 2022 was -7.25%. Cannabis Global's annualized ROC (Joel Greenblatt) % for the quarter that ended in May. 2022 was -51.35%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Cannabis Global's Earnings Yield (Joel Greenblatt) % for the quarter that ended in May. 2022 was 209.76%.

Cannabis Global  (OTCPK:CBGL) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Cannabis Global's annualized ROC % for the quarter that ended in May. 2022 is calculated as:

ROC % (Q: May. 2022 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Feb. 2022 ) + Invested Capital (Q: May. 2022 ))/ count )
=-1.372 * ( 1 - 0% )/( (18.933 + 18.894)/ 2 )
=-1.372/18.9135
=-7.25 %

where

Invested Capital(Q: Feb. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=15.148 - 0.894 - ( 0.604 - max(0, 5.962 - 1.283+0.604))
=18.933

Invested Capital(Q: May. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=14.909 - 0.832 - ( 0.253 - max(0, 6.114 - 1.297+0.253))
=18.894

Note: The Operating Income data used here is four times the quarterly (May. 2022) data.

2. Joel Greenblatt's definition of Return on Capital:

Cannabis Global's annualized ROC (Joel Greenblatt) % for the quarter that ended in May. 2022 is calculated as:

ROC (Joel Greenblatt) %(Q: May. 2022 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Feb. 2022  Q: May. 2022
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-0.82/( ( (1.615 + max(-2.351, 0)) + (1.579 + max(-2.033, 0)) )/ 2 )
=-0.82/( ( 1.615 + 1.579 )/ 2 )
=-0.82/1.597
=-51.35 %

where Working Capital is:

Working Capital(Q: Feb. 2022 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.452 + 0.196 + 0.0099999999999998) - (0.894 + 0 + 2.115)
=-2.351

Working Capital(Q: May. 2022 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.405 + 0.198 + 0.42) - (0.832 + 0 + 2.224)
=-2.033

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (May. 2022) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Cannabis Global's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: May. 2022 )
=1.376/0.656
=209.76 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannabis Global EBIT Related Terms

Cannabis Global EBIT Historical Data

* Premium members only.

The historical data trend for Cannabis Global's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannabis Global EBIT Chart

Cannabis Global Annual Data
Trend Aug12 Aug13 Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.00 -0.05 -0.38 -3.51 -0.68

Cannabis Global Quarterly Data
Aug17 Nov17 Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.91 -1.84 1.63 1.79 -0.21

CBGL vs MILC, BBBT, GCAN: EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Global's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannabis Global EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Global's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cannabis Global's EV-to-EBIT falls into.


Cannabis Global EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in May. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.38 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $1.38 Mil mean?
Cannabis Global (CBGL) has a EBIT of $1.38 Mil as of May. 2022. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Cannabis Global.
Is Cannabis Global's EBIT too high?
Cannabis Global's current EBIT is $1.38 Mil.
How does Cannabis Global's EBIT compare to MILC and BBBT?
Cannabis Global's EBIT of $1.38 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Drug Manufacturers company?
A good EBIT depends on the Drug Manufacturers industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Cannabis Global. Cannabis Global's current EBIT is $1.38 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabis Global stock overvalued right now?
Cannabis Global (CBGL) has a current EBIT of $1.38 Mil. The current EBIT is $1.38 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Cannabis Global (CBGL), the current EBIT is $1.38 Mil as of May. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cannabis Global Business Description

Address 520 S Grand Avenue, Suite 320, Los Angeles, CA, USA, 90071
Cannabis Global Inc manufactures and distributes various cannabis products via its majority ownership of Natural Plant Extract, Inc is developing the Ethos Comply Bag, and generally conducts research and development in the areas of hemp, cannabis and consumer food goods. The company also have an active research and development program focused on creating and commercializing engineered technologies that deliver hemp extracts and cannabinoids to the human body. Its product includes cannabis flower packaged in various weights, cannabis Pre-rolls, cannabis edible products.